Pediatrics
From the Journals
Should Cancer Trial Eligibility Become More Inclusive?
A new study highlights the potential benefits of broadening eligibility criteria for clinical trials.
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Feature
Cancer Drug Shortages Continue in the US, Survey Finds
Not having enough of a significant spectrum of generic chemotherapies and supportive care medications is an ongoing issue, NCCN surveys suggest....
Latest News
Study Finds Variations in Pediatric Dermatologists Who Accept Medicaid
More research is needed on “the impact on health outcomes when specialty services are unavailable,” the authors wrote.
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Photo Challenge
Vascular Mass on the Posterior Neck in a Newborn
A newborn male was delivered via cesarean section at 38 weeks 5 days’ gestation with a large vascular mass on the posterior neck. The mass...
Conference Coverage
Neurofilament Light Chain Detects Early Chemotherapy-Related Neurotoxicity
“Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.
Feature
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?
The number of community practices acquired by hospitals nearly tripled from 2010 to 2020, according to a report from COA.
Case Letter
Treatment of Infantile Hemangiomas in Concomitant Tuberous Sclerosis Complex Should Prompt Evaluation for Cardiac Rhabdomyomas Prior to Initiation of Propranolol
Dermatologists may see patients with infantile hemangiomas (IHs) and tuberous sclerosis complex (TSC); therefore, they should be familiar with TSC...
Latest News
FDA Approves Topical Anticholinergic for Axillary Hyperhidrosis
Approval was based on results from two phase 3 studies that enrolled 710 patients with primary axillary hyperhidrosis.
Conference Coverage
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis
Ixekizumab has taken a major step toward its approval for the treatment of psoriatic arthritis and enthesitis-related arthritis in children, based...